From our Annual Public Meeting to topic-specific convenings, the Reagan-Udall Foundation for the FDA brings stakeholders together on matters critical to regulatory science and practice. These events, often hosted at the request of FDA leadership, provide space for expert analysis and candid discussion on FDA’s priority issues. See below for upcoming events.

Upcoming Events

Innovations in Regulatory Science & Policy Awards

Nominations Open! Help Us Recognize Leaders, Innovators, & Advocates

Past Events

Primary Mitochondrial Diseases

The Reagan-Udall Foundation for the FDA, in collaboration with the Food and Drug Administration (FDA), hosted a virtual, public workshop to explore opportunities to optimize therapeutic development to address primary mitochondrial diseases.

2024 Innovations in Regulatory Science Awards

Innovations in Regulatory Science Awards spotlight exceptional contributions to regulatory science and public health. 2024 honorees included Dr. Jeff Shuren and Steven A. Grossman.

Real-World Evidence Webinar Series: Integrating Randomized Controlled Trials for Drug and Biological Products Into Routine Clinical Practice

The Reagan-Udall Foundation for the FDA, in collaboration with the Food and Drug Administration (FDA), hosted a public webinar as part of a series of webinars for FDA-issued guidance related to real-world evidence (RWE).

Introduction to Innovation in Medical Evidence and Development Surveillance (IMEDS): The Research Resource

On October 30, 2024, we held a one-hour session on IMEDS, a flagship program of the Regan-Udall Foundation for the FDA.

Biosimilar Roundtables

The Reagan-Udall Foundation for the FDA conducted a series of five closed-door virtual roundtable conversations with biosimilar developers to explore emerging areas of regulatory science and to create a space for active discussion and exploration between FDA and biosimilar developers.

LDT Industry Education: Record Keeping and Adverse Event Reporting

Record Keeping and Adverse Event Reporting: Medical Device Reporting, Corrections and Removals and Quality System Complaint Requirements LDT Industry Education

Advancing Rare Disease Therapies Through an FDA Rare Disease Innovation Hub

The Reagan-Udall Foundation for the FDA, in collaboration with FDA’s Rare Disease Innovation Hub, hosted a public meeting on October 16, 2024.

Virtual Public Meeting on FDA's Final Rule on Requirements for Additional Traceability Records for Certain Foods

On October 7, we hosted a virtual public meeting to hear insights on the Final Rule on Requirements for Additional Traceability Records from both FDA leadership and other experts from across food industry sectors.

Advancing Treatments for Post-Traumatic Stress Disorder

The Reagan-Udall Foundation for the FDA, in support of FDA’s ongoing focus on PTSD, convened “Advancing Treatments for Post-Traumatic Stress Disorder,” a public meeting with stakeholder comment.

Scientific Advancements in Gene Therapies: Opportunities for Global Regulatory Convergence

The Reagan-Udall Foundation for the FDA, in collaboration with the Bill & Melinda Gates Foundation, will host a hybrid public workshop on "Scientific Advancements in Gene Therapies: Opportunities for Global Regulatory Convergence."